1. Home
  2. Analysis
  3. Budesonide
  4. Aromasin

Budesonide and Aromasin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Budesonide (budesonide) and Aromasin (exemestane). Common drug interactions include neuropathy peripheral among females.

The phase IV clinical study analyzes what interactions people have when they take Budesonide and Aromasin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.

What is Aromasin?

Aromasin has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 12,863 Aromasin users. Check the latest studies of Aromasin.

On Aug, 09, 2026

16 people who take Budesonide and Aromasin together, and have interactions are studied.

Budesonide and Aromasin drug interactions.

What are the common drug interactions of Budesonide and Aromasin, by gender? *:

female:

  1. Neuropathy peripheral (surface nerve damage)
  2. Hypokalaemia (low potassium)
  3. Diarrhoea
  4. Dry skin
  5. Ejection fraction decreased (systolic heart failure)
  6. Lacrimation increased
  7. Memory impairment
  8. Nail dystrophy (bed formation of nail)
  9. Panic attack
  10. Pruritus (severe itching of the skin)

male:

n/a

What are the common drug interactions of Budesonide and Aromasin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Platelet count decreased

40-49:

n/a

50-59:

n/a

60+:

  1. Hypokalaemia (low potassium)
  2. Neuropathy peripheral (surface nerve damage)
  3. Chest discomfort
  4. Constipation
  5. Dry skin
  6. Ejection fraction decreased (systolic heart failure)
  7. Lacrimation increased
  8. Memory impairment
  9. Nail dystrophy (bed formation of nail)
  10. Panic attack

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 11 people, 68.75%
  2. Infection: 9 people, 56.25%
  3. Abdominal Discomfort: 9 people, 56.25%
  4. Constipation: 5 people, 31.25%
  5. Panic Disorder: 3 people, 18.75%
  6. Lacrimation Increased: 3 people, 18.75%
  7. Itching: 3 people, 18.75%
  8. Insomnia (sleeplessness): 3 people, 18.75%
  9. Metastases To Bone (cancer spreads to bone): 2 people, 12.50%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Budesonide and Aromasin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Budesonide and Aromasin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Budesonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aromasin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Budesonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aromasin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on budesonide and exemestane (the active ingredients of Budesonide and Aromasin, respectively), and Budesonide and Aromasin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.